Delivery Order SPE2DB20D3103-SPE2DB22FN1D0
- Not listed
- This federal contract award is for the delivery of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $83,437.62. This is a firm fixed-price delivery order contract with a period of performance ending on February 28, 2024. The contract was awarded on February 27, 2024, with no set-aside designation,...
- The federal contract award is for the delivery of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price of $15,942.66 and has an ultimate completion date of September 10, 2021. This award is not designated with a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- This federal contract award is for the delivery of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML medical products. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, in the amount of $32,854.08. The contract is a Firm Fixed Price Delivery Order with a completion date of May 17, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
- This federal contract award, valued at $9,547.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a critical medication used in various medical treatments. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora,...
- This federal contract award, valued at $8,386.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a specialty pharmaceutical product. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on July 10, 2024 with a ceiling value of $41,584.00. This is a firm-fixed-price delivery order contract with a completion date of July 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $28,844.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a pharmaceutical product. The award has a firm fixed-price pricing type and an ultimate completion date of February 3, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,481.11 firm fixed price delivery order is for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a specialty pharmaceutical product. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
- The federal contract award is for the delivery of Gonal-F RFF Redi-Ject 300 unit 0.5ml pharmaceutical products to the Defense Logistics Agency (DLA). The $1,018.38 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor. The contract does not have any set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award, valued at $93,128.18, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for the pharmaceutical product GONAL-F RFF REDI-JECT 450 UNIT 0.75ML, with a performance period ending on May 14, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, to...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FN1D0Delivery Order
This federal contract award is for the delivery of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The award, with a ceiling value of $77,435.10, was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $77.4k | 3/23/22 |